• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Search
Generic filters
Home » News » All News

All News

  • Member News
  • Industry News
  • LSBC in The News
Member News

InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019

November 5, 2019 – InMed Pharmaceuticals Inc.

Vancouver, BC – November 4, 2019 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade… Read More

Member News

Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics with a $57 Million Series A

November 5, 2019 – Innovative Targeting Solutions Inc.

Vancouver BC – November 5th, 2019 – Innovative Targeting Solutions (ITS) today announced that, A2 Biotherapeutics, Inc., co-founded in 2018 with Alexander Kamb, former SVP of Research at Amgen Inc., has… Read More

Member News

DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083

November 5, 2019 – LSBC Comms

SAN DIEGO, Nov. 5, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, today announced it will host… Read More

Member News

DR. MICHAEL HAYDEN JOINS ABCELLERA’S BOARD OF DIRECTORS

October 31, 2019 – LSBC Comms

October, 31, 2019, Vancouver, B.C., – AbCellera, a leader in therapeutic antibody discovery from natural immune systems, has appointed Dr. Michael Hayden to its Board of Directors. Dr. Hayden replaces former… Read More

Member News

Arbutus to Report Third Quarter 2019 Financial Results

October 30, 2019 – LSBC Comms

WARMINSTER, Pa., Oct. 30, 2019 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third quarter financial results, conference call… Read More

  • ←
  • Go to page 1
  • Interim pages omitted …
  • Go to page 286
  • Go to page 287
  • Go to page 288
  • Go to page 289
  • Go to page 290
  • Interim pages omitted …
  • Go to page 307
  • →

Primary Sidebar

  • Category:

  • Sector:

  • Archives:

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us